8-K filing — Nuwellis, Inc. (NUWE)
Filed: 2026-08-26 AccNo: 0001140361-26-034367 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Nuwellis Stock Explodes Thursday: What's Driving the Action?
Nuwellis shares are surging Thursday afternoon as traders react to new pediatric data tied to the company’s Aquadex ultrafiltration therapy.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 30, 2026, 8:01 PM
- Checked
- Jul 30, 2026, 8:00 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Nuwellis Announces Co-Promotion And Distribution Agreement With Atrility Medical For AtriAmp, Starting With Six-Month Program In Three Territories; Terms Not Disclosed
Read original at benzingaNuwellis Q2 2026 Earnings Call Transcript
Nuwellis (NASDAQ:NUWE) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data
Read original at benzingaNuwellis Q2 EPS $(26.64) Misses $(0.68) Estimate, Sales $1.969M Miss $2.415M Estimate
Read original at benzinga